AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2026
Jan 14, 2026
31660_dirs_2026-01-14_45fd676d-646a-46ac-bea5-95b3605adabb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2026-01-12
Reporting Person: LO FRANCIS (Chief People Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-12 | Common Stock | M | 36650 | $7.8 | Acquired | 352628 | Direct |
| 2026-01-12 | Common Stock | M | 7723 | $12.14 | Acquired | 360351 | Direct |
| 2026-01-12 | Common Stock | M | 21002 | $8.46 | Acquired | 381353 | Direct |
| 2026-01-12 | Common Stock | M | 14215 | $3.99 | Acquired | 395568 | Direct |
| 2026-01-12 | Common Stock | S | 79590 | $17.73 | Disposed | 315978 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Stock Option (right to buy) | $7.8 | M | 36650 | Disposed | 2029-05-06 | Common Stock (36650) | Direct |
| 2026-01-12 | Stock Option (right to buy) | $12.14 | M | 7723 | Disposed | 2032-03-04 | Common Stock (7723) | Direct |
| 2026-01-12 | Stock Option (right to buy) | $8.46 | M | 21002 | Disposed | 2033-03-06 | Common Stock (21002) | Direct |
| 2026-01-12 | Stock Option (right to buy) | $3.99 | M | 14215 | Disposed | 2034-03-04 | Common Stock (14215) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2500 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
F2: The option is fully vested and exercisable.
F3: The options vested with respect to 1/4 of such shares on March 4, 2023, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4: The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F5: The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.